Tricuspid annuloplasty in the rheumatic mitralvalve replacement
Main Article Content
Abstract
OBJECTIVE: Uncorrected secondary tricuspid regurgitation has serious long-term morbidity and mortality. We reviewed our experience with the bypass by PTFE band to bridge the righ fibrous trigone and tricuspid posterior annular bicuspidization for treatment of functional tricuspid regurgitation.
METHODS: From 12- 2010 to 12- 2011, 40 patients (mean age, 47,73 ± 4,17 years) underwent combined mitral valve replacement and tricuspid valve repair for rheumatic disease, the tricuspid annuloplasty for secondary tricuspid regurgitation with our method. Preoperatively,40 (100%) patients had moderate or severe tricuspid regurgitation. Pre and postoperative, NYHA and 2D transthoracic echocardiograms were assessed for tricuspid regurgitation. Follow-up time was 8±2 months.
RESULTS: At 8 months postoperatively, tricuspid regurgitation in patients treated by our method of annuloplasty was zero to mild in 30(75%), moderatein 9(22,5%), severe in 1(2,5%) of patients.No risk
factors of our technic.
CONCLUSIONS: Our bypass- annuloplasty were effective at eliminating tricuspid regurgitation at 8 monhts postoperatively. this annuloplasty is a simple, inexpensive option for addressing functional tricuspid regurgitation. All patients with moderate-to-severe functional tricuspid regurgitation should undergo tricuspid annuloplasty regardless the technique
Article Details
Keywords
NYHA: New York Heart Association; PTFE:Polytetrafluorethylene.
References
2. Braunwald NS, Ross J, Jr, servative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation 1967, 35(4 Suppl):I63–I69.,
3. Carpentier A. Cardiac valve surgery—the “French correction.” JThorac Cardiovasc Surg 1983; 86(3):323 – 337.
4.King RM, Schaff HV, Danielson GK, et al.: Surgery for tricuspid regurgitation late after mitral valve
replacement.Circulation 1984, 70(3 Pt 2): I193–I197
5.Porter A, Shapira Y, Wurzel M, et al.: Tricusid Regurgitation late after mitral valve replacement: clinical and echocardiographic evaluation. J Heart Valve Dis 1999, 8:57–62
6. Sagie A, Schwammenthal E, Newell JB, et al.:Sinificant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty
J AM Coll Cardiol 1994, 24:696–702.
7. Song H, Kang DH, Kim JH, et al.: Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation 2007,116(11 Suppl): I246–I250.
8. Sagie A, Schwammenthal E, Palacios IF, et al.:Significant tricuspid regurgitation does not resolve afterpercutaneous balloon mitral valvotomy.J Thorac Cardiovasc Surg 1994,108: 727-75..
9. Sagie A, Schwammenthal E, Padial LR, et al.:Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients. JAm Coll Cardiol 1994, 24:446–453.
10. Fukuda S, Gillinov ocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation. Am Heart J 2006,152:1208–1214.
11. Ton-Nu TT, Levine RA, Handschumacher MD, et al.: Geometric determinants urgitation: insights from 3-dimensional echocardiography. Circulation 2006, 114:143–149.14. Tei C, Pilgrim JP, Shah PM, et al.
12. Fukuda S, Saracino G, Matsumura Y, et al.: Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study. Circulation 2006, 114(1Suppl 1):I492–I498.
13. Sukmawan R, Watanabe N, Ogasawara Y, et al.: Geometricchange of tricuspid regurgitationsecondary to pulmonary hypertension quantified by novelsystem with transthoracic real-time 3-dimensional echocardiography.J Am Soc Echocardiogr 2007.
14. Mogollon MV, Lage E, Cabezon S, et al.: Combination therapy with sildenafil and bosentan reverts severe pulmonaryhypertension and allows heart transplantation: case report. Transplant Proc
2006, 38:2522–2523.
15. McCarthy PM, Bhudia SK, Rajeswaran J,et al.: Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004, 127:674–685.
16. Carpentier A, Deloche A, Dauptain J, et al.: A new reconstruct tricuspid insufficiency. J Thorac Cardiovasc Surg 1971, 61:1–13.
17. De Vega NG, De Rabago G, Castillon L, et al.: A new tricuspid repair. Short term clinical results in 23 cases . J Cardiovasc Surg (Torino) 1973, Spec No:384–386.
18. Tang GH, David TE, Sigh SK, et al: Tricuspid valve repairwith an annuloplasty ring results in improved long-term
19. Jerome Harold Tricuspid Regurgitation (Ann Thorac Surg 1992;53:1132-3) 23.
20. Farzan Filsoufi,M.D., Sacha P. Salzberg, M.D., Vivian Abascal, M.D., AND David H. AdamsM.D.Surgical tricuspid Regurgitation with a New Remodeling Annuloplasty Ring..
21. A Propensity Analysis.Robert J. Moraca, MD, Marc R. Moon, MD, Michael K. Pasque, MD, and
Ralph J. Damiano, Jr, MD. Outcomes of Tricupid Valve Repair and Replacement(Ann Thorac Surg
2009;87:83–9)
22. Deloche A., Guerinon J, Fabiani JN, et al., Anatomical study of rheumatic tricuspid valvulopathies. Applications to the various methods of annuloplasty (French). ArchMal
Coeur Vaiss 1974; 67(5):497 – 505)
23. Tiến triển của hở van 3 lá nặng sau phẫu thuật van 2 lá ở người bệnh van tim hậu thấ, ThS. Hồ Huỳnh Quang Trí,PGS. TS. Phạm Nguyễn Vinh,Viện Tim TP.HCM. Báo Cardiologie.vn.năm 2010
Similar Articles
- Tran Thuc Khang, Bui Duc Phu, EARLY OUTCOMES OF TRICUSPID VALVE REPAIR FOR FUNCTIONAL MODERATE TRICUSPID REGURGITATION IN PATIENTS UNDERGOING POST-RHEUMATIC MITRAL VALVE SURGERY , The Vietnam Journal of Cardiovascular and Thoracic Surgery: Vol. 2
You may also start an advanced similarity search for this article.